跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pharmaceutical active ingredients and intermediates
首页
药物
Pharmaceutical active ingredients and intermediates
Pharmaceutical active ingredients and intermediates
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHOSPONATE NUCLEOSIDES USEFUL AS ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS, AND INTERMEDIATES FOR THEIR PRODUCTION
EP 2980095 A1
申请人: LEUVEN K U RES & DEV
优先权: 2004
EP
US
10 件公开
NAPHTHYRIDINE AND PYRIDO[3,4-C]PYRIDAZINE DERIVATIVES AS GABAA ALPHA5 RECEPTOR MODULATORS
EP 4126859 A1
申请人: RICHTER GEDEON NYRT
优先权: 2020
CN
EP
US
5 件公开
1,3-dihydro-2H-pyrrolo[3,4-c]pyridine derivatives as GABA A α5 receptor modulators
US 12649738 B2
申请人: RICHTER GEDEON NYRT
优先权: 2020
EP
US
WO
5 件公开
BICYCLIC AMINE DERIVATIVES AS GABAA a5 RECEPTOR MODULATORS
EP 4408842 A1
申请人: RICHTER GEDEON NYRT
优先权: 2021
CN
EP
US
WO
4 件公开
ENVIRONMENTAL ATTRIBUTES FOR ACTIVE PHARMACEUTICAL INGREDIENTS AND/OR INTERMEDIATES THEREOF
EP 4732210 A1
申请人: BASF SE
优先权: 2023
CN
EP
WO
4 件公开
Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists
US 7786144 B2
申请人: SOLVAY PHARM BV
优先权: 2007
US
4 件公开
CN 101454291 A
申请人: SOLVAY PHARM BV
优先权: 2006
CN
PROCESS FOR THE PREPARATION OF A CHIRAL PYRROLO TRIAZOLE ALCOHOL
EP 4727925 A2
申请人: HOFFMANN LA ROCHE
优先权: 2023
EP
US
WO
3 件公开
Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
US 7851627 B2
申请人: EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG
优先权: 2005
CN
US
3 件公开
Substituted phenoxypyridines
US 9045429 B2
申请人: HITCHCOCK MARION
优先权: 2010
CN
US
3 件公开
Carbon sorbent for removal of metal catalysts from pharmaceuticals
US 11077421 B2
申请人: TDA RESEARCH INC
优先权: 2016
US
WO
3 件公开
第 1 / 4 页
上一页
下一页
药物
反馈